Clinical Trial Update: Study of LW231 in Participants With Chronic Hepatitis B [Phase 1, Phase 2]

View source ↗

Summary

Ongoing Phase 1/2 clinical trial of LW231 for chronic hepatitis B, with recruiting status and sponsor Shanghai Longwood Biopharmaceuticals Co., Ltd.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• LW231

Snippet

Sponsor: Shanghai Longwood Biopharmaceuticals Co., Ltd. | Conditions: Chronic HBV Infection | Phase 1, Phase 2 | Status: RECRUITING